- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07364539
Local Registry of Central Nervous System Infections (ReCeNSI) (ReCeNSI)
January 21, 2026 updated by: Raffaella Lissandrin, Fondazione IRCCS Policlinico San Matteo di Pavia
Central Nervous System (CNS) infections are considered rare conditions but at the same time, they are emergencies whose diagnosis and treatment are time-dependent.
They include several clinical syndromes, including meningitis, encephalitis, brain abscesses, and post-surgical meningitis.
The classic triad of symptoms includes fever, altered mental status, and neck stiffness, but other common manifestations include nausea and vomiting, cranial nerve dysfunction, skin rash, and seizures.
Due to the potentially life-threatening effects on patients, these clinical conditions cannot be underestimated.
The CNS includes the brain and spinal cord, surrounded and protected by the meninges and cerebrospinal fluid (CSF).
Within the CNS are numerous nuclei responsible for vital functions, as well as more complex intellectual activities.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
520
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Italia
-
Pavia, Italia, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo di Pavia
-
Contact:
- Raffaella Lissandrin
- Phone Number: 3355853501
- Email: r.lissandrin@smatteo.pv.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
In the nine years since 2012, we have identified 260 patients with positive CSF tests.
We assume that over the next 10 years we will register the same number of patients, for a total of 520 patients.
With this sample size, the precision of the mortality estimate over the study period will be at worst ±4.3%, corresponding to half the 95% confidence interval (CI) of a 50% chance.
If the mortality rate were 10%, the precision would be ±2.7%;
if the mortality rate were 5%, the precision would be ±2%.
Description
- Pazients admitted to the Fondazione IRCSS Policlinico San Matteo
- Diagnosis of bacterial meningitis, meningoencephalitis, bacterial CNS infection, viral CNS infection, viral encephalitis, brain abscess, or post-neurosurgical meningitis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To evaluate the outcome in terms of mortality at discharge in patients with CNS infections.
Time Frame: From January 2012
|
From January 2012
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2022
Primary Completion (Actual)
March 5, 2022
Study Completion (Estimated)
January 1, 2030
Study Registration Dates
First Submitted
December 19, 2025
First Submitted That Met QC Criteria
January 21, 2026
First Posted (Actual)
January 23, 2026
Study Record Updates
Last Update Posted (Actual)
January 23, 2026
Last Update Submitted That Met QC Criteria
January 21, 2026
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReCeNSI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Nervous System (CNS) Infection
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaActive, not recruitingInfection | CNS Infection | Virus DiseaseItaly
-
Sohag UniversityNot yet recruiting
-
Xuanwu Hospital, BeijingNot yet recruitingEncephalitis | Meningitis | Central Nervous System (CNS) InfectionChina
-
Arbor Pharmaceuticals, Inc.Completed
-
Mayo ClinicCompleted
-
Mayo ClinicCompleted
-
Huashan HospitalUnited Imaging HealthcareRecruiting
-
Rigshospitalet, DenmarkRecruitingCNS Tumor, ChildhoodDenmark
-
Tata Memorial CentreBhabha Atomic Research Centre (BARC)Recruiting
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland